This substantial investment will allow Pearl to push forward with its innovative dental AI technologies, expanding its product line, enhancing its regulatory and patent portfolio, and increasing global access to AI's benefits in dentistry. Pearl's machine learning and computer vision tools address a critical issue in dentistry: inconsistent diagnostic accuracy. These AI tools provide dentists with real-time assistance in reading x-rays, ensuring consistent, objective, and precise diagnoses, and facilitating clear communication of findings to patients.

Following the first-ever FDA clearance for AI software to assist dental professionals in detecting various pathologies and conditions in x-rays, Pearl's clinical AI has gained regulatory approval in over 120 countries and earned recognition among TIME’s Best Inventions. The new funding will accelerate the development of advanced computer vision capabilities, including 3D disease detection and tracking, and introduce new AI tools to enhance patient treatment planning, insurance claim approvals, and dental education.

“In the field of healthcare, dentistry has become an AI standard-bearer, demonstrating the technology’s enormous utility and benefit in day-to-day patient care - and Pearl has led the AI charge in dentistry,” said Ophir Tanz, founder and CEO of Pearl.  This historic funding round underscores the impact of Pearl’s capabilities and supports our belief that high-quality, AI-powered dental care should be accessible to everyone. With this investment, Pearl will continue to push the envelope, providing pioneering machine learning to improve oral health outcomes and strengthen trust between the patient and dental professionals.”

This investment comes on the heels of a remarkable growth phase for Pearl. In 2023, the company saw its revenue surge by 458%, solidifying its position as the sole dental AI provider with a truly global footprint. Pearl’s cutting-edge technology is now utilised in dental practices on six continents, reaching over 500,000 dental offices and millions of professionals worldwide.

Additionally, Pearl has seamlessly integrated its AI solutions into numerous popular imaging and practice management systems, becoming the preferred radiologic AI provider for top dental technology distributors. This widespread adoption underscores Pearl’s pivotal role in transforming dental care through artificial intelligence.

"We have spent the past year evaluating this market and it is clear that Pearl stands above peers at the forefront of dental innovation," said Vinny Pujji, Managing Partner at Left Lane Capital. "Pearl's pioneering dental Al improves diagnostic accuracy and efficiency while transforming the provider-patient relationship. We're confident in Pearl's ability to continue setting new standards of care and are thrilled to support their next phase of growth."

Pearl’s AI technology revolutionises dental diagnostics with a seamless and minimally invasive approach. The company's FDA-cleared software accurately detects diseases and presents clinical findings in a patient-friendly manner. This enhances the efficiency, consistency, and precision of radiologic exams while promoting patient education and involvement in their dental care. With the new funding, Pearl aims to empower dental professionals to elevate the standard of care, providing more transparent, accurate, and objective diagnoses, delivering more effective personalised treatment, and fostering deeper patient trust in the dental field.